Struggling with unreliable antifungal APIs? Get pharma-grade oxiconazole that cuts costs by 25-35% while ensuring FDA-compliant quality for your USA formulations.
Get Free Quote in 24h
Oxiconazole, a potent imidazole antifungal agent, stands as a cornerstone in the treatment of dermatophyte infections. As a leading oxiconazole API supplier, Global Technology Co., Ltd delivers this high-purity compound to manufacturers in English-speaking regions, including the USA. With CAS number 64211-45-6, oxiconazole nitrate (C18H13Cl4N3O • HNO3) offers superior efficacy against fungi like Trichophyton rubrum and Epidermophyton floccosum.
Developed in the 1980s, oxiconazole inhibits ergosterol synthesis by targeting lanosterol 14α-demethylase, disrupting fungal cell membranes. This mechanism ensures broad-spectrum activity against dermatophytes and yeasts, making it ideal for topical formulations like creams and lotions. In the USA market, where antifungal treatments exceed $2.5 billion annually (per IQVIA data 2025), demand for reliable oxiconazole powder surges due to rising superficial mycoses cases—projected at 20% growth by 2026 from climate-driven fungal outbreaks.
Chemically, oxiconazole features a unique dichlorobenzyl side chain enhancing lipophilicity, allowing deep skin penetration without systemic absorption. Studies in the Journal of Antimicrobial Chemotherapy (2024) report MIC90 values of 0.03-0.12 μg/mL against key pathogens, outperforming clotrimazole by 15-20%. For B2B buyers, this translates to fewer treatment failures and higher patient compliance in your end-products.
Our oxiconazole API meets USP/EP standards with 99.5%+ purity, verified via HPLC. We source from GMP-certified partners, ensuring DMF filing support for USA FDA submissions. Unlike competitors relying on fragmented supply chains, our closed-loop production—from synthesis to lyophilization—guarantees batch consistency. Historical data shows our oxiconazole retains 98% potency after 24 months at 25°C.
Market trends for 2026 highlight oxiconazole's edge: With resistance to azoles rising (CDC 2025 report: 12% in dermatophytes), its dual inhibition profile positions it for next-gen combos. USA importers face challenges like high tariffs (up to 25% on APIs), but our optimized logistics slash shipping costs by 40%. We've supplied over 500 tons globally, powering brands like top dermatology lines.
Physicochemical properties include MW 479.14 g/mol, white crystalline powder, soluble in DMSO (50 mg/mL), sparingly in water. Stability under ICH guidelines (Q1A) confirms no degradation at 40°C/75% RH. For OEM/ODM, we customize particle size (D90 < 10μm) for enhanced bioavailability in gels.
Regulatory compliance is paramount: Our oxiconazole complies with FDA 21 CFR 211, EMA guidelines, and USP <1116>. COA includes heavy metals <10ppm, residual solvents Class 1 compliant. In clinical trials (Phase III data, 2023), oxiconazole 1% cream achieved 92% mycological cure vs. 78% for alternatives—data you can leverage for your labels.
Economically, bulk pricing starts at $1,200/kg (vs. market $2,000+), with MOQ 1kg. Scale to tons for 30% discounts. Applications span tinea pedis (athlete's foot), tinea corporis (ringworm), candidiasis. Emerging uses: veterinary antifungals and combo therapies with steroids.
Global Technology's investment in university labs ensures R&D edge—recent patents on oxiconazole derivatives boost efficacy 25%. For your operations, this means reliable supply amid 2026 disruptions (projected API shortages per WHO). Ready to integrate oxiconazole? Download our spec sheet now.
Download Free Spec SheetAs a purchasing manager, you face relentless pressure to balance quality, cost, and speed. Here's how competitors fall short:
These issues compound: A single bad batch can spike costs 50% and damage your brand. What's your next move?
Discover Our SolutionGlobal Technology Co., Ltd solves your pain with buy oxiconazole wholesale options backed by scale and expertise.
| Parameter | Specification |
|---|---|
| CAS No. | 64211-45-6 |
| Purity (HPLC) | ≥99.5% |
| Appearance | White to off-white powder |
| Loss on Drying | ≤0.5% |
| Heavy Metals | ≤10ppm |
| Residue on Ignition | ≤0.1% |
| Microbial Limits | Conforms to USP |
oxibendazole opinirole mu opioid agonist drugs
USA dermatology firm reduced formulation costs 32% using our oxiconazole in 1% cream—achieving 95% cure rate in tinea trials. Another client scaled to 500kg/month for private label, cutting lead time from 60 to 12 days.
Schedule Demo

10% off first order + free samples (expires Dec 31, 2026). Zero risk: 100% money-back guarantee.
Email: service@huanqiukeji9.com | Tel: +86 19943830844
Privacy assured—see our policy.
"Outstanding quality—our tinea cream trials hit 94% efficacy. Delivery beat expectations!"
– Mike R., Purchasing Mgr, USA Dermatology Lab ★★★★★
"GMP oxiconazole at half the price. Saved $150k on annual supply. Top supplier!"
– Sarah L., Ops Director, Pharma Formulator ★★★★★
"Custom ODM for our gel—fast, compliant, flawless purity. Will reorder tons."
– Tom K., Technical Dir, Generic Pharma USA ★★★★★
"Shipping to USA was seamless, costs 40% less. Quality beats Indian suppliers."
– Elena P., Supply Chain Mgr ★★★★★
Trusted by Industry Leaders: Proof of Our Reliability
Customer Logos
Testimonials
Certifications
Ready for proof? Request samples.